CA Koller

613 total citations
15 papers, 510 citations indexed

About

CA Koller is a scholar working on Molecular Biology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, CA Koller has authored 15 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in CA Koller's work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). CA Koller is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). CA Koller collaborates with scholars based in United States and Russia. CA Koller's co-authors include KA Foon, RG Steis, DL Longo, HM Kantarjian, MJ Keating, Raymond Alexanian, Razelle Kurzrock, AF LoBuglio, Hagop M. Kantarjian and Michael J. Keating and has published in prestigious journals such as Blood, PubMed and Proceedings of the American Association for Cancer Research.

In The Last Decade

CA Koller

14 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CA Koller United States 7 179 178 168 136 109 15 510
JJ Hutton United States 7 173 1.0× 112 0.6× 84 0.5× 61 0.4× 72 0.7× 9 374
MJ Keating United States 6 120 0.7× 452 2.5× 181 1.1× 145 1.1× 272 2.5× 9 641
GH Reaman United States 11 251 1.4× 89 0.5× 341 2.0× 103 0.8× 88 0.8× 17 635
A. Raghavachar Germany 9 116 0.6× 155 0.9× 284 1.7× 104 0.8× 104 1.0× 14 564
E A Harden United States 7 107 0.6× 44 0.2× 148 0.9× 87 0.6× 22 0.2× 8 375
K Hirashima Japan 12 99 0.6× 99 0.6× 295 1.8× 134 1.0× 31 0.3× 44 465
F. T. Cordingley United Kingdom 9 76 0.4× 205 1.2× 90 0.5× 57 0.4× 126 1.2× 13 471
BS Andersson United States 9 124 0.7× 95 0.5× 379 2.3× 240 1.8× 149 1.4× 10 615
Maria Arroz Portugal 7 129 0.7× 90 0.5× 173 1.0× 92 0.7× 86 0.8× 14 378
Ching Hon Pui United States 10 214 1.2× 86 0.5× 379 2.3× 82 0.6× 50 0.5× 12 665

Countries citing papers authored by CA Koller

Since Specialization
Citations

This map shows the geographic impact of CA Koller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Koller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Koller more than expected).

Fields of papers citing papers by CA Koller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CA Koller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Koller. The network helps show where CA Koller may publish in the future.

Co-authorship network of co-authors of CA Koller

This figure shows the co-authorship network connecting the top 25 collaborators of CA Koller. A scholar is included among the top collaborators of CA Koller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CA Koller. CA Koller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Kurzrock, Razelle, Hagop M. Kantarjian, CA Koller, et al.. (1991). 2-Chlorodeoxyadenosine: A new anticancer agent in lymphoid malignancies. 43(3). 253–258. 3 indexed citations
4.
Kantarjian, HM, Raymond Alexanian, CA Koller, Razelle Kurzrock, & MJ Keating. (1990). Fludarabine therapy in macroglobulinemic lymphoma. Blood. 75(10). 1928–1931. 2 indexed citations
5.
Kantarjian, HM, Raymond Alexanian, CA Koller, Razelle Kurzrock, & MJ Keating. (1990). Fludarabine therapy in macroglobulinemic lymphoma. Blood. 75(10). 1928–1931. 76 indexed citations
6.
7.
Koller, CA & Beverly S. Mitchell. (1984). Erythrocyte adenosine triphosphate and deoxyadenosine triphosphate measurements predict toxicity following 2'- deoxycoformycin therapy. 2. 67–74. 1 indexed citations
8.
Koller, CA, et al.. (1984). Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells.. PubMed. 165. 227–39. 3 indexed citations
9.
Koller, CA, et al.. (1983). Deoxyribonucleoside triphosphate accumulation by leukemic cells. Blood. 62(2). 419–424. 1 indexed citations
10.
Koller, CA, et al.. (1983). Deoxyribonucleoside triphosphate accumulation by leukemic cells. Blood. 62(2). 419–424. 17 indexed citations
11.
Koller, CA & Mitchell. (1981). 2'-Deoxycoformycin toxicity correlates with red cell dATP/ATP ratios. Proceedings of the American Association for Cancer Research. 22. 3 indexed citations
12.
Koller, CA & AF LoBuglio. (1981). Monocyte-mediated antibody-dependent cell-mediated cytotoxicity: the role of the metabolic burst. Blood. 58(2). 293–299. 25 indexed citations
13.
Koller, CA & AF LoBuglio. (1981). Monocyte-mediated antibody-dependent cell-mediated cytotoxicity: the role of the metabolic burst. Blood. 58(2). 293–299. 1 indexed citations
14.
Koller, CA, et al.. (1980). Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo. Blood. 56(3). 556–559. 66 indexed citations
15.
Koller, CA, et al.. (1980). Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo. Blood. 56(3). 556–559. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JJ Hutton Breakdown of academic impact, for papers by MJ Keating Breakdown of academic impact, for papers by GH Reaman Breakdown of academic impact, for papers by A. Raghavachar Breakdown of academic impact, for papers by E A Harden Breakdown of academic impact, for papers by K Hirashima Breakdown of academic impact, for papers by F. T. Cordingley Breakdown of academic impact, for papers by BS Andersson Breakdown of academic impact, for papers by Maria Arroz Breakdown of academic impact, for papers by Ching Hon Pui
Rankless by CCL
2026